Literature DB >> 18669974

Treatment of hepatitis C in patients with thalassemia.

Emanuele Angelucci, Federica Pilo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18669974     DOI： 10.3324/haematol.13500

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  4 in total

1.  Prevalence of anti HCV infection in patients with Beta-thalassemia in isfahan-iran.

Authors:  Behrooz Ataei; Marjan Hashemipour; Nazila Kassaian; Razieh Hassannejad; Zary Nokhodian; Peyman Adibi
Journal:  Int J Prev Med       Date:  2012-03

2.  Safety and Efficacy of Sofosbuvir and Daclatasvir for Hepatitis C Virus Infection in Patients with β-Thalassemia Major.

Authors:  Rajiv Mehta; Mayank Kabrawala; Subhash Nandwani; Pankaj Desai; Vishwa Bhayani; Sanjay Patel; Viral Parekh
Journal:  J Clin Exp Hepatol       Date:  2017-06-23

Review 3.  Safety and Efficacy of Adding Ribavirin to Interferon or Peginterferon in Treatment of Hepatitis C Infection in Patients With Thalassemia: A Systematic Review on Randomized Controlled Trials.

Authors:  Ehsan Aminizadeh; Seyed Moayyed Alavian; Ali Akbari Sari; Nasser Ebrahimi Daryani; Bita Behnava
Journal:  Hepat Mon       Date:  2016-03-06       Impact factor: 0.660

Review 4.  Hepatocellular carcinoma in adult thalassemia patients: an expert opinion based on current evidence.

Authors:  Alessandra Mangia; Davide Bellini; Umberto Cillo; Andrea Laghi; Giuseppe Pelle; Vanna Maria Valori; Eugenio Caturelli
Journal:  BMC Gastroenterol       Date:  2020-08-03       Impact factor: 3.067
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.